A. Braun

An Open-Label Trial of Divalproex Extended-Release in the Treatment of Borderline Personality Disorder

E. Hollander, W. Chaplin, D. Simeon, 2007, CNS Spectrums.

Cross-cutting issues and future directions for the OCD spectrum

E. Hollander, J. Zohar, D. Simeon, 2009, Psychiatry Research.

Neurological considerations: Autism and Parkinson's disease

E. Hollander, L. Marsh, A. T. Wang, 2009, Psychiatry Research.

Oxytocin can hinder trust and cooperation in borderline personality disorder.

Suah Kim, Holly Hamilton, Eric Hollander, 2011, Social cognitive and affective neuroscience.

Oxytocin administration attenuates stress reactivity in borderline personality disorder: A pilot study

E. Hollander, S. Ketay, H. Hamilton, 2011, Psychoneuroendocrinology.

Preliminary physiological evidence for impaired emotion regulation in depersonalization disorder

T. Giesbrecht, S. Ketay, D. Simeon, 2013, Psychiatry Research.

A double-blind, placebo-controlled trial of topiramate for pathological gambling

E. Hollander, S. McElroy, L. Koran, 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Should OCD leave the anxiety disorders in DSM‐V? The case for obsessive compulsive‐related disorders

E. Hollander, D. Simeon, A. Braun, 2008, Depression and anxiety.